Skip to main content
Premium Trial:

Request an Annual Quote

LabBook Announces Content, Equity Deal with John Wiley

NEW YORK, April 12 – LabBook said Thursday it had reached an agreement to make John Wiley & Sons’ scientific content available through its Genomic XML Browser.

Under the terms of the deal, Wiley of New York has also acquired an equity stake in LabBook, marking the second equity investment in as many days that LabBook has announced.

On Wednesday, LabBook said IBM took an equity stake in the company as part of a strategic alliance to combine LabBook's desktop information retrieval, integration, mining, and visualization software with IBM's back-end data management, data integration, and Internet infrastructure software.

“Our overall strategy has been to partner with like-minded companies that are interested in providing an excellent environment for scientists,” said Adel Mikhail, vice president of corporate development at LabBook.

Mikhail declined to disclose the size of the equity stakes, but said Wiley’s stake was “substantial.”

Mikhail said the deal with Wiley would give LabBook customers access to the company’s 300 scientific, technical, and medical journals as well as its reference works and scientific protocols and allow them to combine the information with their own empirical data. The customers' accounts will remain with LabBook, which will share revenues with Wiley.

In addition to its genomic XML browser, LabBook has developed an extensible markup language for bioinformatics and a bioinformatics sequence markup language that are designed to retain semantic content, allowing researchers to derive more meaning from the data, Mikhail said.

Researchers can test LabBook’s genomic XML viewer for free at .

Mikhail noted that the company was now looking to provide its technology to companies that offer genomic content.

LabBook expects to make several new announcements “very soon” regarding new customers and new features in its genomic browser, Mikhail said.

LabBook has offices in McLean, Va., and Columbus, Ohio.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.